1. Home
  2. ARMP vs BKTI Comparison

ARMP vs BKTI Comparison

Compare ARMP & BKTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ARMP

Armata Pharmaceuticals Inc.

HOLD

Current Price

$9.69

Market Cap

383.7M

Sector

Health Care

ML Signal

HOLD

Logo BK Technologies Corporation

BKTI

BK Technologies Corporation

HOLD

Current Price

$76.00

Market Cap

332.2M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARMP
BKTI
Founded
N/A
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Radio And Television Broadcasting And Communications Equipment
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
383.7M
332.2M
IPO Year
1996
2000

Fundamental Metrics

Financial Performance
Metric
ARMP
BKTI
Price
$9.69
$76.00
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$15.00
$74.00
AVG Volume (30 Days)
43.0K
31.2K
Earning Date
01-01-0001
06-17-2026
Dividend Yield
N/A
N/A
EPS Growth
53.40
52.89
EPS
N/A
3.44
Revenue
N/A
$74,094,000.00
Revenue This Year
N/A
$12.00
Revenue Next Year
N/A
$11.30
P/E Ratio
N/A
$22.67
Revenue Growth
N/A
45.42
52 Week Low
$0.90
$28.35
52 Week High
$13.75
$89.50

Technical Indicators

Market Signals
Indicator
ARMP
BKTI
Relative Strength Index (RSI) 47.29 36.35
Support Level $5.14 $74.50
Resistance Level $12.23 $76.69
Average True Range (ATR) 1.09 5.09
MACD -0.24 -1.34
Stochastic Oscillator 2.16 32.21

Price Performance

Historical Comparison
ARMP
BKTI

About ARMP Armata Pharmaceuticals Inc.

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology. The company is developing and advancing a broad pipeline of natural and synthetic phage candidates, including clinical candidates for Pseudomonas aeruginosa, Staphylococcus aureus, and other pathogens. In addition, in collaboration with Merck, the company is developing proprietary synthetic phage candidates to target an undisclosed infectious disease agent.

About BKTI BK Technologies Corporation

BK Technologies Corp a holding company, operates through its subsidiary, BK Technologies, Inc., specializing in designing, manufacturing, and marketing wireless communications equipment. Its Radio business unit offers two-way land mobile radios (LMRs) serving government and public safety markets, as well as industrial and commercial enterprises. The SaaS business unit focuses on public safety smartphone applications, enhancing first responders' safety and efficiency. The BKRplay application, tethered to BK radios, amplifies user capabilities, expanding the reach of their radio sales. Its product portfolio consists of two-way land mobile radios, handheld radios, radios installed in vehicles.

Share on Social Networks: